The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Neuropsychiatric decision making: the role of disorder prevalence in diagnostic testing

Published Online:https://doi.org/10.1176/jnp.3.1.84

Although the performance of medical diagnostic tests is usually described in terms of their sensitivity and specificity, these accuracy indices by themselves are of little help to clinicians who need to make decisions about patient care. Estimating the probability that a patient with a positive or negative test has or lacks a disorder requires the clinician to include the pretest probability of the disorder in the interpretation of the test result. This article described several approaches to the problem of interpreting diagnostic data in actual clinical contexts.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.